Dynatronics Corporation

Equities

DYNT

US2681575005

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:00:00 2024-04-17 pm EDT 5-day change 1st Jan Change
0.585 USD +6.36% Intraday chart for Dynatronics Corporation +46.29% 0.00%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Transcript : Dynatronics Corporation, Q2 2024 Earnings Call, Feb 08, 2024
Earnings Flash (DYNT) DYNATRONICS Reports Q2 Revenue $8.2M MT
Dynatronics Corporation Provides Sales Guidance for the Full Year 2024 CI
Dynatronics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI
Dynatronics Corporation Announces Board and Committee Changes CI
Tranche Update on Dynatronics Corporation's Equity Buyback Plan announced on February 14, 2011. CI
Transcript : Dynatronics Corporation, Q1 2024 Earnings Call, Nov 09, 2023
Earnings Flash (DYNT) DYNATRONICS Reports Q1 Revenue $9.4M MT
Dynatronics Corporation Reports Earnings Results for the First Quarter Ended September 30, 2023 CI
Dynatronics Corporation Announces CFO Changes CI
North American Morning Briefing : Treasury Yields -2- DJ
Ladenburg Thalmann Downgrades Dynatronics to Neutral From Buy, Cuts Price Target to $3.80 From $6.50 MT
Dynatronics Corporation Appoints John Krier as Interim Chief Financial Officer CI
Dynatronics Corporation Appoints John Krier as Interim Principal Accounting Officer CI
Tranche Update on Dynatronics Corporation's Equity Buyback Plan announced on February 14, 2011. CI
Dynatronics Corporation Reports Earnings Results for the Full Year Ended June 30, 2023 CI
Earnings Flash (DYNT) DYNATRONICS Posts Q4 Revenue $8.4M MT
Dynatronics Corporation Provides Revenue Guidance for the Fiscal Year 2024 CI
Transcript : Dynatronics Corporation, Q4 2023 Earnings Call, Sep 28, 2023
North American Morning Briefing : Rising Oil -2- DJ
Dynatronics Corporation Announces Executive Changes CI
Dynatronics Corporation Announces Chief Executive Officer Changes CI
Tranche Update on Dynatronics Corporation's Equity Buyback Plan announced on February 14, 2011. CI
Dynatronics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023 CI
Transcript : Dynatronics Corporation, Q3 2023 Earnings Call, May 11, 2023
Chart Dynatronics Corporation
More charts
Dynatronics Corporation is a medical device company engaged in providing restorative products designed to accelerate achieving optimal health. The Company designs, manufactures, and sells a range of products for clinical use in physical therapy, rehabilitation, orthopedics, pain management, and athletic training. Through its distribution channels, the Company markets and sells to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, and hospitals. The Company's products are marketed under a portfolio of brands, including Bird & Cronin, Solaris, Hausmann, PROTEAM, and Mammoth, among others. Its orthopedic soft bracing products are designed to accelerate health for patients both pre- and post-surgical intervention, and during fracture recovery, joint stabilization, and ligament injury. The Company’s Solaris, Hausmann, PROTEAM, and Mammoth brands include products for physical therapy, rehabilitation, and athletic training.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.585 USD
Average target price
4 USD
Spread / Average Target
+583.76%
Consensus
  1. Stock Market
  2. Equities
  3. DYNT Stock
  4. News Dynatronics Corporation
  5. Dynatronics : Sees Higher Fiscal Q4 Sales